How the body gets rid of MRI contrast dye
This study looks at how gadolinium, a contrast agent used in MRI scans, leaves the body through urine. It aims to learn more about how the drug is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a prescription for an MRI with contrast dye
- You have health insurance
- You can give written permission to be in the study
- You have no known allergy to gadolinium contrast agents
- Your kidneys are working well (not on dialysis and no severe kidney disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects urine after a CT scan with contrast dye to study how to reduce dye in hospital wastewater. You may help by using a special urine collection device.
This study looks at whether getting the MRI contrast dye multiple times over 5 years affects body movement and thinking skills. It compares people who had the dye repeatedly with people who have little or no exposure, using brain MRI scans and regular mental and movement testing.
This study tests different MRI imaging techniques to improve how scans look and measure targets. You may be able to join with or without a contrast dye, and you’ll need to travel to the NIH for follow-up visits.
This trial tests whether a newer contrast agent, gadopiclenol, works as well as the standard one for liver scans. It might be an option if you need an MRI to check for liver disease, tumors, or treatment response.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
This study tests a new contrast agent (a dye injected before an MRI) to see how well it works for people having brain or spinal cord scans. It aims to improve image quality so doctors can see lesions more clearly, which may help with diagnosis and treatment planning.
Hear when a new Magnetic Resonance Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.